Dupont Capital Management Corp Boston Scientific Corp Transaction History

Dupont Capital Management Corp

$1.14 Billion
Q2 2024

A detailed history of Dupont Capital Management Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Dupont Capital Management Corp holds 168,810 shares of BSX stock, worth $14 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

168,810

Previous 201,075 16.05%

Holding current value

$14 Million

Previous $13.8 Million 5.6%

% of portfolio

1.14%

Previous 1.15%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$67.33 - $77.71 $2.17 Million - $2.51 Million	-32,265 Reduced 16.05%	168,810 $13 Million
Q1 2024 Apr 23, 2024	SELL	$57.6 - $68.62 $1.85 Million - $2.2 Million	-32,095 Reduced 13.76%	201,075 $13.8 Million
Q4 2023 Jan 23, 2024	SELL	$48.64 - $57.81 $3.79 Million - $4.51 Million	-77,941 Reduced 25.05%	233,170 $13.5 Million
Q3 2023 Oct 27, 2023	BUY	$50.19 - $54.68 $8.96 Million - $9.76 Million	178,488 Added 134.58%	311,111 $16.4 Million
Q2 2023 Jul 25, 2023	BUY	$49.72 - $54.64 $1.03 Million - $1.13 Million	20,705 Added 18.5%	132,623 $7.17 Million
Q1 2023 Apr 28, 2023	BUY	$45.09 - $50.03 $1.04 Million - $1.15 Million	23,065 Added 25.96%	111,918 $5.6 Million
Q4 2022 Jan 26, 2023	BUY	$39.56 - $47.22 $728,932 - $870,075	18,426 Added 26.16%	88,853 $0
Q3 2022 Oct 31, 2022	SELL	$36.71 - $109.66 $1.85 Million - $5.54 Million	-50,518 Reduced 41.77%	70,427 $2.73 Million
Q2 2022 Jul 26, 2022	SELL	$35.24 - $47.1 $683,691 - $913,787	-19,401 Reduced 13.82%	120,945 $4.51 Million
Q1 2022 Apr 27, 2022	SELL	$40.9 - $45.1 $484,378 - $534,119	-11,843 Reduced 7.78%	140,346 $6.22 Million
Q4 2021 Jan 31, 2022	SELL	$38.07 - $44.87 $1.56 Million - $1.84 Million	-41,094 Reduced 21.26%	152,189 $6.47 Million
Q3 2021 Nov 03, 2021	SELL	$41.23 - $45.88 $2.26 Million - $2.51 Million	-54,736 Reduced 22.07%	193,283 $8.39 Million
Q2 2021 Jul 30, 2021	BUY	$38.58 - $44.24 $3 Million - $3.45 Million	77,878 Added 45.77%	248,019 $10.6 Million
Q1 2021 Apr 29, 2021	SELL	$35.27 - $39.67 $1.66 Million - $1.86 Million	-46,948 Reduced 21.63%	170,141 $6.58 Million
Q4 2020 Jan 28, 2021	SELL	$33.15 - $41.97 $300,305 - $380,206	-9,059 Reduced 4.01%	217,089 $7.8 Million
Q3 2020 Oct 29, 2020	SELL	$34.44 - $42.23 $520,181 - $637,841	-15,104 Reduced 6.26%	226,148 $8.64 Million
Q2 2020 Jul 24, 2020	BUY	$30.19 - $39.11 $5.09 Million - $6.59 Million	168,516 Added 231.68%	241,252 $8.47 Million
Q1 2020 Apr 29, 2020	BUY	$25.83 - $45.71 $43,032 - $76,152	1,666 Added 2.34%	72,736 $2.37 Million
Q4 2019 Jan 27, 2020	SELL	$37.87 - $45.37 $620,765 - $743,705	-16,392 Reduced 18.74%	71,070 $3.21 Million
Q3 2019 Oct 28, 2019	BUY	$40.31 - $43.45 $440,427 - $474,734	10,926 Added 14.28%	87,462 $3.56 Million
Q2 2019 Jul 30, 2019	SELL	$34.91 - $42.98 $2.02 Million - $2.49 Million	-57,829 Reduced 43.04%	76,536 $3.29 Million
Q1 2019 Apr 30, 2019	SELL	$32.91 - $40.75 $611,467 - $757,135	-18,580 Reduced 12.15%	134,365 $5.16 Million
Q4 2018 Feb 01, 2019	BUY	$31.73 - $39.04 $25,637 - $31,544	808 Added 0.53%	152,945 $5.41 Million
Q3 2018 Nov 05, 2018	SELL	$32.83 - $38.63 $498,195 - $586,210	-15,175 Reduced 9.07%	152,137 $5.86 Million
Q2 2018 Jul 30, 2018	BUY	$26.84 - $34.32 $96,731 - $123,689	3,604 Added 2.2%	167,312 $5.47 Million
Q1 2018 May 02, 2018	BUY	$25.2 - $28.54 $3.63 Million - $4.12 Million	144,196 Added 739.01%	163,708 $4.47 Million
Q4 2017 Jan 31, 2018	BUY	$24.79 - $29.8 $265,600 - $319,277	10,714 Added 121.78%	19,512 $484,000
Q3 2017 Oct 31, 2017	BUY	$26.26 - $29.17 $231,035 - $256,637	8,798	8,798 $257,000

Others Institutions Holding BSX

# of Institutions

1,448

Shares Held

1.21B

Call Options Held

8.14M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $119B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account

Dupont Capital Management Corp Boston Scientific Corp Transaction History